The split Renilla luciferase complementation assay is useful for identifying the interaction of Epstein-Barr virus protein kinase BGLF4 and a heat shock protein Hsp90
Related Experiment Video
Updated: Mar 24, 2026
Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
Abstract:
Protein-protein interactions can regulate different cellular processes, such as transcription, translation, and oncogenic transformation. The split Renilla luciferase complementation assay (SRLCA) is one of the techniques that detect protein-protein interactions. The SRLCA is based on the complementation of the LN and LC non-functional halves of Renilla luciferase fused to possibly interacting proteins which after interaction form a functional enzyme and emit luminescence. The BGLF4 of Epstein-Barr virus (EBV) is a viral protein kinase that is expressed during the early and late stages of lytic cycles, which can regulate multiple cellular and viral substrates to optimize the DNA replication environment. The heat shock protein Hsp90 is a molecular chaperone that maintains the integrity of structure and function of various interacting proteins, which can form a complex with BGLF4 and stabilize its expression in cells. The interaction between BGLF4 and Hsp90 could be specifically detected through the SRLCA. The region of aa 250-295 of BGLF4 is essential for the BGLF4/Hsp90 interaction and the mutation of Phe-254, Leu-266, and Leu-267 can disrupt this interaction. These results suggest that the SRLCA can specifically detect the BGLF4/Hsp90 interaction and provide a reference to develop inhibitors that disrupt the BGLF4/Hsp90 interaction.
Insights
The split Renilla luciferase complementation assay (SRLCA) detects protein-protein interactions, specifically identifying the interaction between Epstein-Barr virus (EBV) protein BGLF4 and heat shock protein Hsp90.
Area of Science:
- Virology
- Molecular Biology
- Biochemistry
Background:
- Protein-protein interactions are crucial for cellular processes, including viral replication.
- Epstein-Barr virus (EBV) protein BGLF4 is a viral protein kinase involved in optimizing viral DNA replication.
- Heat shock protein Hsp90 acts as a molecular chaperone, stabilizing interacting proteins like BGLF4.
Purpose of the Study:
- To investigate the interaction between EBV's BGLF4 and human Hsp90.
- To validate the use of the split Renilla luciferase complementation assay (SRLCA) for detecting this specific interaction.
- To identify key regions and residues of BGLF4 involved in Hsp90 binding.
Main Methods:
- Utilized the split Renilla luciferase complementation assay (SRLCA) to detect protein-protein interactions.
- Fused BGLF4 and Hsp90 to non-functional halves of Renilla luciferase (LN and LC).
- Introduced specific mutations in the BGLF4 protein (aa 250-295, including Phe-254, Leu-266, Leu-267) to assess their impact on interaction.
Main Results:
- The SRLCA successfully detected the interaction between BGLF4 and Hsp90.
- A specific region (aa 250-295) of BGLF4 was identified as essential for Hsp90 binding.
- Mutations Phe-254, Leu-266, and Leu-267 within this region disrupted the BGLF4/Hsp90 interaction.
Conclusions:
- The SRLCA is a reliable method for specifically detecting the BGLF4/Hsp90 interaction.
- The findings provide a basis for developing inhibitors targeting the BGLF4/Hsp90 interaction.
- Understanding this interaction is vital for comprehending EBV replication mechanisms.
More Related Videos
05:28Demonstration of Heterologous Complexes formed by Golgi-Resident Type III Membrane Proteins using Split Luciferase Complementation Assay
Published on: September 10, 2020
12:53Identification of Protein Interaction Partners in Mammalian Cells Using SILAC-immunoprecipitation Quantitative Proteomics
Published on: July 6, 2014